Athersys, Inc   Report issue

For profit Phase 2 Phase 3
Founded: Cleveland OH United States (1995)

Organization Overview

First Clinical Trial
2008
NCT00677222
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Athersys, Inc | Athersys Limited